Literature DB >> 24606481

Association between the metabolic syndrome and high tumor grade and stage of primary urothelial cell carcinoma of the bladder.

Emin Ozbek1, Alper Otunctemur, Murat Dursun, Ismail Koklu, Suleyman Sahin, Huseyin Besiroglu, Mustafa Erkoc, Eyyup Danis, Muammer Bozkurt.   

Abstract

PURPOSE: To compare histopathologic findings of patients who underwent transurethral resection of a bladder tumor (TUR-B) between groups with and without the metabolic syndrome.
MATERIALS AND METHODS: We retrospectively analyzed data of 535 patients who underwent TUR-B in our department between October 2005 and March 2011. All patients had primary urethelial cell carcinoma (UCB). Histologic stage, grade, the presence of hypertension, diabetes mellitus, body mass index (BMI), waist circumference, HDL and trigliseride levels were evaluated. The TNM classification was used, with Ta tumor accepted as lower stage and T1 and T2 tumors as higher stage bladder cancers. Also, the pathological grading adopted by the 2004 World Health Organization grading system were applied. Non-invasive papillary urothelial neoplasms of low malignant potential were regarded as low grade.
RESULTS: Among the total of 509 patients analyzed in our study, there were 439 males (86.2%) and 70 females (13.8%). Metabolic syndrome was significantly associated with high histologic grade, and high pathologic stage (p<0.001).
CONCLUSIONS: The patients with metabolic syndrome were found to have statistically significant higher T stage and grade of bladder cancer. Further studies with more patients are needed to confirm our study.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24606481     DOI: 10.7314/apjcp.2014.15.3.1447

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Optimal body mass index cut-point for predicting recurrence-free survival in patients with non-muscle-invasive urothelial carcinoma of bladder.

Authors:  Satoru Yonekura; Fumihito Terauchi; Kenji Hoshi; Takehiko Yamaguchi; Shigeo Kawai
Journal:  Oncol Lett       Date:  2018-07-04       Impact factor: 2.967

2.  Modulation of Calcium Homeostasis May Be Associated with Susceptibility to Renal Cell Carcinoma in Diabetic Nephropathy Rats.

Authors:  Yueming Luo; Zhaoyu Lu; Ana Maria Waaga-Gasser; Haifeng Yang; Jialing Liu; Juan Wu; Jiayan Lu; Xusheng Liu; Lei Zhang
Journal:  Cancer Manag Res       Date:  2020-10-07       Impact factor: 3.989

3.  Diabetes mellitus and ovarian cancer: more complex than just increasing risk.

Authors:  Monjri M Shah; Britt K Erickson; Tasnia Matin; Gerald McGwin; Jovana Y Martin; Laura Becca Daily; Daniel Pasko; Christen W Haygood; Janelle M Fauci; Charles A Leath
Journal:  Gynecol Oncol       Date:  2014-09-16       Impact factor: 5.482

4.  The association between metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study in China.

Authors:  Sheng Xu; Gui-Ming Zhang; Feng-Ju Guan; Da-Hai Dong; Lei Luo; Bin Li; Xiao-Cheng Ma; Jun Zhao; Li-Jiang Sun
Journal:  World J Surg Oncol       Date:  2015-08-07       Impact factor: 2.754

5.  Is metabolic syndrome associated with high tumor grade and stage of bladder cancer: a systematic review and meta-analysis.

Authors:  Dechao Feng; Pan Song; Yubo Yang; Wuran Wei; Li Li
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.